Evidence map›Paper›PMID 41366100›Full record

ArticleEMBO reports2026

An Argonaute protein traffics from nematode to mouse and is a vaccine against parasitic nematodes.

Kyriaki Neophytou, Isaac Martínez-Ugalde, Thomas M Fenton, Elaine Robertson, Lewis J Strachan, Vignesh Jayaraman, Yvonne Harcus, Chanel M Naar, David Wright, Daniel R G Price and 9 more

Abstract read
In one paragraph

Article in EMBO reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Kyriaki NeophytouInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0003-4311-9776
Isaac Martínez-UgaldeInstitute of Ecology and Evolution, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.
Thomas M FentonInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0002-6200-6403
Elaine RobertsonInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.
Lewis J StrachanInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0009-0004-9668-292X
Vignesh JayaramanInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.
Yvonne HarcusInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.
Chanel M NaarInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0003-3054-7472
David WrightInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0001-8666-4155
Daniel R G PriceDepartment of Vaccines and Diagnostics, Moredun Research Institute, Edinburgh, EH26 0PZ, UK.ORCID 0000-0002-4819-0654
Ruby WhiteInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0002-2503-9169
Michael J EvansInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0002-2332-4425
José Roberto Bermúdez-BarrientosInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.
Hanchen LiUniversity of Massachusetts Chan Medical School, Program in Molecular Medicine, Worcester, MA, 01605, USA.
Rick M MaizelsSchool of Immunity & Infection, University of Glasgow, Glasgow, G12 8TA, UK.ORCID 0000-0003-3216-1944
Raffi V AroianUniversity of Massachusetts Chan Medical School, Program in Molecular Medicine, Worcester, MA, 01605, USA.
Alasdair J NisbetDepartment of Vaccines and Diagnostics, Moredun Research Institute, Edinburgh, EH26 0PZ, UK.ORCID 0000-0002-4965-5396
Cei Abreu-GoodgerInstitute of Ecology and Evolution, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK.ORCID 0000-0001-8302-9893
Amy H BuckInstitute of Immunology and Infection Research, School of Biological Sciences, The University of Edinburgh, Edinburgh, EH9 3FL, UK. a.buck@ed.ac.uk.ORCID 0000-0003-2645-7191

Funding

Function/optimization of a nematicidal Cry toxin arsenalR01AI056189 · NIAID · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI RAFFI V AROIAN · 2005 to 2026
$11.0M
A dual-purpose vaccine targeting blood-feeding nematode parasites of sheep and humansR01HD099072 · NICHD · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI AROIAN, RAFFI V · 2019 to 2023
$2.4M
Consejo Nacional de Humanidades, Ciencias y Tecnologías (Conahcyt) CVU: 896776; Scholarship number: 765004EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC) 101002385HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 1R01-HD099072NIAID NIH HHS R01 AI056189NICHD NIH HHS R01 HD099072Wellcome TrustWellcome Trust 226791Wellcome Trust (WT) 108905/Z/15/Z
6 · The paper itself

Abstract

Argonautes are ancient proteins with well-characterised functions in cell-autonomous gene regulation and genome defence, but less clear roles in non-cell-autonomous processes. Extracellular Argonautes have been reported across plants, animals and protozoa, yet their biochemical and functional properties remain elusive. Here, we demonstrate that an extracellular Argonaute (exWAGO) released by the rodent-infective nematode Heligmosomoides bakeri is detectable inside mouse cells during the natural infection. We show that exWAGO is released from H. bakeri in both vesicular and non-vesicular forms that have different resistances to proteolysis, different accessibilities to antibodies and associate with different subsets of secondary siRNAs. Using recombinant exWAGO protein, we demonstrate that non-vesicular exWAGO is internalised by mouse cells in vitro and that immunisation of mice with exWAGO confers partial protection against subsequent H. bakeri infection and generates antibodies that block exWAGO uptake into cells. Finally, we show that properties of exWAGO are conserved across Clade V nematodes that infect humans and livestock. Together, this work expands the context in which Argonautes function and illuminates an RNA-binding protein as a vaccine target for parasitic nematodes.

Indexed as

Argonaute ProteinsHelminth ProteinsStrongylida InfectionsVaccinesAnimalsHumansMiceProtein TransportRNA, Small InterferingArgonaute ProteinsHelminth ProteinsRNA, Small InterferingVaccinesArgonauteExtracellular RNAHost–PathogenNematodeRNA Interference

Identifiers

PMID41366100
PMCPMC12852730

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.